Dr. Kathryn Sutton, MD
Claim this profileChildren's Healthcare of Atlanta - Egleston
Studies Langerhans Cell Histiocytosis
Studies Solid Tumors
5 reported clinical trials
24 drugs studied
Area of expertise
1Langerhans Cell Histiocytosis
2Solid Tumors
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Kathryn Sutton, MD is currently running
DAY101
for Langerhans Cell Histiocytosis
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Recruiting1 award Phase 228 criteria
Sirolimus + Chemotherapy
for High-Risk Pediatric Cancers
The primary objective of this study is to improve the 2-year progression-free survival in children with high-risk solid tumors who are administered a maintenance regimen with continuous sirolimus administered on a backbone of metronomic chemotherapy following the completion of "standard" therapy, as compared to high-risk solid tumor patients treated with observation alone following completion of "standard" therapy.
Recruiting3 awards Phase 2
More about Kathryn Sutton, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kathryn Sutton, MD has experience with
- Cyclophosphamide
- 2-chlorodeoxyadenosine
- Cytosine Arabinoside
- Hematopoietic Stem Cell Transplantation (RIC-HSCT)
- INDOMETHACIN
- Intravenous Immunoglobulin
Breakdown of trials Kathryn Sutton, MD has run
Langerhans Cell Histiocytosis
Fibrolamellar Carcinoma
Hepatoblastoma
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn Sutton, MD specialize in?
Kathryn Sutton, MD focuses on Langerhans Cell Histiocytosis and Solid Tumors. In particular, much of their work with Langerhans Cell Histiocytosis has involved treating patients, or patients who are undergoing treatment.
Is Kathryn Sutton, MD currently recruiting for clinical trials?
Yes, Kathryn Sutton, MD is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Kathryn Sutton, MD has studied deeply?
Yes, Kathryn Sutton, MD has studied treatments such as Cyclophosphamide, 2-chlorodeoxyadenosine, Cytosine Arabinoside.
What is the best way to schedule an appointment with Kathryn Sutton, MD?
Apply for one of the trials that Kathryn Sutton, MD is conducting.
What is the office address of Kathryn Sutton, MD?
The office of Kathryn Sutton, MD is located at: Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia 30322 United States. This is the address for their practice at the Children's Healthcare of Atlanta - Egleston.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.